NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A couple in Vancouver transitioned from corporate careers in fashion and tech to cofound No Reception Club and create travel products for parents.Read More